Participants are needed for both of the Health Science Center-based trials.
Recruitment is under way for that study, as well.
PCOS, also known as Stein-Leventhal Syndrome, is one of the leading causes of infertility in women, but it affects more than reproduction. Data on metformin have shown evidence of success in increasing ovulation and regulating the menstrual cycle. A second study that is expected to last three months will focus on chromium picolinate, an essential element that plays a role in glucose and insulin metabolism. Dr. Thyer will study the effects of the element on menstrual cycles, insulin sensitivity and ovulation rates. Without treatment, women who have PCOS may develop more serious conditions.